A detailed history of Strategy Asset Managers LLC transactions in Medtronic PLC stock. As of the latest transaction made, Strategy Asset Managers LLC holds 45,618 shares of MDT stock, worth $4.07 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
45,618
Previous 37,544 21.51%
Holding current value
$4.07 Million
Previous $3.27 Million 9.75%
% of portfolio
0.71%
Previous 0.7%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$78.71 - $87.02 $635,504 - $702,599
8,074 Added 21.51%
45,618 $3.59 Million
Q1 2024

Apr 25, 2024

BUY
$82.84 - $88.09 $1.3 Million - $1.38 Million
15,713 Added 71.98%
37,544 $3.27 Million
Q4 2023

Feb 12, 2024

SELL
$69.43 - $83.43 $860,515 - $1.03 Million
-12,394 Reduced 36.21%
21,831 $1.8 Million
Q3 2023

Nov 09, 2023

SELL
$78.22 - $90.4 $891,160 - $1.03 Million
-11,393 Reduced 24.97%
34,225 $2.68 Million
Q2 2023

Aug 24, 2023

BUY
$79.47 - $91.38 $459,813 - $528,724
5,786 Added 14.53%
45,618 $4.02 Million
Q1 2023

May 02, 2023

BUY
$76.72 - $87.58 $387,512 - $442,366
5,051 Added 14.52%
39,832 $3.21 Million
Q4 2022

Jan 13, 2023

BUY
$76.18 - $87.74 $4,494 - $5,176
59 Added 0.17%
34,781 $2.7 Million
Q3 2022

Oct 11, 2022

BUY
$80.75 - $95.31 $255,573 - $301,656
3,165 Added 10.03%
34,722 $2.8 Million
Q2 2022

Jul 13, 2022

SELL
$87.4 - $113.09 $98,936 - $128,017
-1,132 Reduced 3.46%
31,557 $2.83 Million
Q1 2022

Apr 11, 2022

BUY
$100.58 - $112.38 $106,815 - $119,347
1,062 Added 3.36%
32,689 $3.63 Million
Q4 2021

Jan 14, 2022

SELL
$99.53 - $127.75 $455,946 - $585,222
-4,581 Reduced 12.65%
31,627 $3.27 Million
Q3 2021

Dec 14, 2021

BUY
$122.75 - $135.17 $100,900 - $111,109
822 Added 2.32%
36,208 $4.54 Million
Q2 2021

Aug 04, 2021

BUY
$118.19 - $131.5 $129,418 - $143,992
1,095 Added 3.19%
35,386 $4.39 Million
Q1 2021

May 12, 2021

SELL
$111.18 - $119.74 $6,559 - $7,064
-59 Reduced 0.17%
34,291 $4.05 Million
Q4 2020

Feb 10, 2021

SELL
$100.57 - $117.14 $220,449 - $256,770
-2,192 Reduced 6.0%
34,350 $4.02 Million
Q3 2020

Nov 03, 2020

SELL
$90.13 - $108.78 $119,512 - $144,242
-1,326 Reduced 3.5%
36,542 $3.8 Million
Q2 2020

Aug 10, 2020

SELL
$84.11 - $103.33 $27,251 - $33,478
-324 Reduced 0.85%
37,868 $3.47 Million
Q1 2020

May 14, 2020

SELL
$72.92 - $121.3 $65,190 - $108,442
-894 Reduced 2.29%
38,192 $3.45 Million
Q4 2019

Feb 13, 2020

SELL
$104.49 - $114.54 $3.85 Million - $4.22 Million
-36,846 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$98.02 - $111.18 $127,818 - $144,978
-1,304 Reduced 3.42%
36,846 $4 Million
Q2 2019

Aug 14, 2019

BUY
$84.15 - $99.38 $3.21 Million - $3.79 Million
38,150 New
38,150 $3.72 Million
Q1 2019

May 08, 2019

SELL
$82.45 - $93.79 $1.86 Million - $2.12 Million
-22,557 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$85.8 - $99.49 $1.94 Million - $2.24 Million
22,557 New
22,557 $2.05 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $119B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Strategy Asset Managers LLC Portfolio

Follow Strategy Asset Managers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategy Asset Managers LLC with notifications on news.